These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7114312)
41. Lenticular deposits associated with chloroquine Keratopathy. Lal S; Gupta AK Indian J Ophthalmol; 1974 Jun; 22(2):34-5. PubMed ID: 4461692 [No Abstract] [Full Text] [Related]
42. Comparison of psychotropic drug, response cost, and psychotropic drug plus response cost procedures for controlling institutionalized mentally retarded persons. Breuning SE; O'Neill MJ; Ferguson DG Appl Res Ment Retard; 1980; 1(3-4):253-68. PubMed ID: 7337461 [No Abstract] [Full Text] [Related]
43. Hyperdibasicaminoaciduria in a mentally retarded homozygote with a peculiar response to phenothiazines. Kihara H; Valente M; Porter MT; Fluharty AL Pediatrics; 1973 Feb; 51(2):223-9. PubMed ID: 4144453 [No Abstract] [Full Text] [Related]
44. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents. Aman MG; White AJ J Autism Dev Disord; 1988 Sep; 18(3):355-66. PubMed ID: 3170454 [TBL] [Abstract][Full Text] [Related]
45. Association of weight and overactivity in institutionalized mentally retarded adults. Roszkowski MJ; Wallen A Percept Mot Skills; 1979 Aug; 49(1):241-2. PubMed ID: 503742 [TBL] [Abstract][Full Text] [Related]
46. Behavioral monitoring of pharmacological interventions for self-injury. Singh NN; Winton AS Appl Res Ment Retard; 1984; 5(1):161-70. PubMed ID: 6539094 [TBL] [Abstract][Full Text] [Related]
47. Hypothermia Associated With Thioridazine Use in an Intellectually Disabled Patient. Goodbar NH; Foushee JA; Nash K; Connolly LA; Webster LM J Pharm Pract; 2016 Jun; 29(3):250-2. PubMed ID: 26739480 [TBL] [Abstract][Full Text] [Related]
48. Five cases of pigmentary retinopathy associated with thioridazine administration. Hagopian V; Stratton DB; Busiek RD Am J Psychiatry; 1966 Jul; 123(1):97-100. PubMed ID: 5935198 [No Abstract] [Full Text] [Related]
49. Amiodarone keratopathy and lens opacities. Dolan BJ; Flach AJ; Peterson JS J Am Optom Assoc; 1985 Jun; 56(6):468-70. PubMed ID: 4008856 [TBL] [Abstract][Full Text] [Related]
50. WAIS subtest score characteristics of institutionalized mentally retarded samples. Hill AL Percept Mot Skills; 1978 Aug; 47(1):131-4. PubMed ID: 704239 [TBL] [Abstract][Full Text] [Related]
51. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY. GREINER AC; BERRY K Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375 [TBL] [Abstract][Full Text] [Related]
52. [Ophthalmologic study of patients receiving psychotropic drugs]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196 [No Abstract] [Full Text] [Related]
53. Comparison of the Quick Test and the Stanford-Binet, Form L-M for institutionalized mentally retarded adults. Lambirth TT; Panek PE Psychol Rep; 1982 Dec; 51(3 Pt 2):1065-6. PubMed ID: 7167604 [No Abstract] [Full Text] [Related]
54. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy. Baron JB; Rivoalan Y; Morel P Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348 [No Abstract] [Full Text] [Related]
56. Haloperidol, thioridazine and placebo in mentally subnormal patients-serum levels and clinical effects. Väisänen K; Viukari M; Rimón R; Räisänen P Acta Psychiatr Scand; 1981 Mar; 63(3):262-71. PubMed ID: 7015792 [TBL] [Abstract][Full Text] [Related]
57. Long-term usefulness of thioridazine for institutionalized mentally retarded patients. Heistad GT; Zimmermann RL; Doebler MI Am J Ment Defic; 1982 Nov; 87(3):243-51. PubMed ID: 7180884 [TBL] [Abstract][Full Text] [Related]
58. Ocular complications of phenothiazines. Mathalone MB Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613 [No Abstract] [Full Text] [Related]
59. Nortriptyline HCl as a tranquilizer for disturbed mentally retarded patients: a controlled study. Carter CH Am J Med Sci; 1966 Apr; 251(4):465-7. PubMed ID: 5910229 [No Abstract] [Full Text] [Related]